Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Melanoma|Gastrointestinal Cancer|Breast Cancer|Ovarian Cancer|Pancreatic Cancer
Interventions: BIOLOGICAL: Peptide loaded dendritic cell vaccine
Sponsor: National Cancer Institute (NCI)